- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01786330
Do Elastic Abdominal Binders Reduce Post Operative Pain and Blood Loss?
March 10, 2016 updated by: Zachary Kuhlmann, DO
This is a pilot study investigating the use of abdominal binders after cesarean sections.
The researchers are testing whether elastic abdominal binders improve postoperative pain control and reduce postoperative blood loss.
Blood loss and pain control are both concerns after giving birth.
It is hoped that the use of an abdominal binder after giving birth will provide a non-pharmacologic way to to reduce blood loss and manage pain.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kansas
-
Wichita, Kansas, United States, 67214
- Wesley Medical Center
-
Wichita, Kansas, United States, 67214
- Kansas School of Medicine-Wichita
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Cesarean section at term (at least 39 weeks gestation) scheduled in advance
- Singleton gestation confirmed by ultrasound in the current pregnancy
- Body mass index 20-40 kg/m2 (at first prenatal visit or pre-pregnancy)
None of these pregnancy complications in the current pregnancy:
- bleeding disorder or use of anticoagulants other than low-dose heparin
- abnormal placenta (placenta previa or accrete)
- Preoperative hemoglobin less than 10 mg/dL
- Chorioamnionitis (intrauterine infection)
- No chronic pain syndrome (defined as participating in formal chronic pain management within the past year)
- Able to read English and understand spoken English
Exclusion Criteria:
- Onset of labor prior to time when the cesarean was scheduled
Complications during performance of cesarean or discovered during cesarean:
- placenta accreta, increta, or percreta
- vasa previa
- cesarean hysterectomy required for severe hemorrhage
- organ damage during cesarean (cystotomy, enterotomy, ureteral injury)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Group receives elastic abdominal binders after surgery.
Binder used is Procare manufactured by DJO, LLC.
Binders are to be worn for 24 hours after surgery.
|
|
|
Active Comparator: Control
Group receives standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lowest Pain Level Postoperative
Time Frame: 24 hours postoperative
|
SF-MPQ2 Pain assessment scale was used to measure lowest pain level postoperative.
The pain assessment was self-administered.
Lowest pain was reported using a 0 to 10 scale, with 0 being "no pain" and 10 being "pain as bad as you can imagine."
Lowest pain level is reported as means for each participant group.
|
24 hours postoperative
|
|
Average Pain Level Postoperative
Time Frame: 24 hours postoperative
|
SF-MPQ2 Pain assessment scale was used to measure average pain level postoperative.
The pain assessment was self-administered.
Average pain was reported using a 0 to 10 scale, with 0 being "no pain" and 10 being "pain as bad as you can imagine."
Reported average pain level is reported as means for each participant group.
|
24 hours postoperative
|
|
Worst Pain Level Postoperative
Time Frame: 24 hours postoperative
|
SF-MPQ2 Pain assessment scale was used to measure worst pain level postoperative.
The pain assessment was self-administered.
Worst pain was reported using a 0 to 10 scale, with 0 being "no pain" and 10 being "pain as bad as you can imagine."
Worst pain level is reported as means for each participant group.
|
24 hours postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hemoglobin Concentration
Time Frame: 24 hours from baseline
|
Hemoglobin concentration will be assessed 24 hours after surgery by assessing routine post-operative lab values.
Outcome is reported as average difference between pre-operative hemoglobin concentration and post-operative hemoglobin concentration.
The negative number indicates the drop in hemoglobin concentration postoperatively.
|
24 hours from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Zachary Kuhlmann, DO, University of Kansas Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
February 5, 2013
First Submitted That Met QC Criteria
February 5, 2013
First Posted (Estimate)
February 7, 2013
Study Record Updates
Last Update Posted (Estimate)
April 11, 2016
Last Update Submitted That Met QC Criteria
March 10, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 220121565
- 12-049
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Cairo UniversityCompletedCervical Pain | Lumbar Pain SyndromeEgypt
Clinical Trials on Standard of Care
-
brett rasmussenCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Emory UniversityNational Institute of Mental Health (NIMH)Active, not recruitingHiv | Sexual Behavior | Treatment Adherence | Adolescent Behavior | Reproductive Behavior | AIDS | Treatment ComplianceKenya
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Ruijin HospitalRecruitingCOVID-19 PneumoniaChina
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Ziv HospitalNot yet recruiting
-
Hofseth Biocare ASAKGK Science Inc.CompletedCovid-19 | COVIDCanada, Brazil, Hungary, Mexico, Serbia
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted